HRP20050173A2 - Composition containing an androgenous 11?-halogensteroid and a progestational hormone, and male contraceptive based on said comosition - Google Patents

Composition containing an androgenous 11?-halogensteroid and a progestational hormone, and male contraceptive based on said comosition

Info

Publication number
HRP20050173A2
HRP20050173A2 HR20050173A HRP20050173A HRP20050173A2 HR P20050173 A2 HRP20050173 A2 HR P20050173A2 HR 20050173 A HR20050173 A HR 20050173A HR P20050173 A HRP20050173 A HR P20050173A HR P20050173 A2 HRP20050173 A2 HR P20050173A2
Authority
HR
Croatia
Prior art keywords
composition containing
androgenous
halogensteroid
comosition
male contraceptive
Prior art date
Application number
HR20050173A
Other languages
English (en)
Inventor
Nubbemeyer Reinhard
Habenicht Ursula-Friederike
Bohlmann Rolf
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10234525A external-priority patent/DE10234525A1/de
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of HRP20050173A2 publication Critical patent/HRP20050173A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20050173A 2002-07-25 2005-02-22 Composition containing an androgenous 11?-halogensteroid and a progestational hormone, and male contraceptive based on said comosition HRP20050173A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10234525A DE10234525A1 (de) 2002-07-25 2002-07-25 Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
US44940003P 2003-02-25 2003-02-25
PCT/EP2003/008192 WO2004011008A1 (de) 2002-07-25 2003-07-25 ZUSAMMENSETZUNG, ENTHALTEND EIN ANDROGENES 11β-HALOGENSTEROID UND EIN GESTAGEN SOWIE MÄNNLICHES KONTRAZEPTIVUM AUF BASIS DIESER ZUSAMMENSETZUNG

Publications (1)

Publication Number Publication Date
HRP20050173A2 true HRP20050173A2 (en) 2005-04-30

Family

ID=31189299

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050173A HRP20050173A2 (en) 2002-07-25 2005-02-22 Composition containing an androgenous 11?-halogensteroid and a progestational hormone, and male contraceptive based on said comosition

Country Status (17)

Country Link
US (1) US20060100180A1 (pt)
EP (1) EP1524983B1 (pt)
JP (1) JP2006502997A (pt)
KR (1) KR20050025985A (pt)
CN (1) CN1671394A (pt)
AT (1) ATE382355T1 (pt)
AU (1) AU2003251636B2 (pt)
BR (1) BR0312922A (pt)
CA (1) CA2493207A1 (pt)
DE (1) DE50308933D1 (pt)
EC (1) ECSP055629A (pt)
ES (1) ES2299735T3 (pt)
HR (1) HRP20050173A2 (pt)
IL (1) IL166432A0 (pt)
MX (1) MXPA05001017A (pt)
PL (1) PL374317A1 (pt)
WO (1) WO2004011008A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10233723A1 (de) 2002-07-24 2004-02-12 Schering Ag Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
NZ537871A (en) * 2002-07-24 2006-10-27 Schering Ag Microbiological processes for the production of 7 alpha-substituted 11 alpha-hydroxy steroids
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714965A1 (de) * 1987-04-30 1988-11-10 Schering Ag 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
DE19848303A1 (de) * 1998-10-14 2000-04-20 Schering Ag Kombination aus Gestagenen und Zuckern
ATE474580T1 (de) * 2000-02-15 2010-08-15 Bayer Schering Pharma Ag Zusammensetzung zur männlichen kontrazeption, norethisteron enthaltend
EP1216699A1 (de) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
ES2299735T3 (es) 2008-06-01
MXPA05001017A (es) 2005-06-08
KR20050025985A (ko) 2005-03-14
ECSP055629A (es) 2005-04-18
BR0312922A (pt) 2005-07-12
AU2003251636B2 (en) 2009-10-22
IL166432A0 (en) 2006-01-15
EP1524983B1 (de) 2008-01-02
US20060100180A1 (en) 2006-05-11
AU2003251636A1 (en) 2004-02-16
PL374317A1 (en) 2005-10-03
WO2004011008A1 (de) 2004-02-05
JP2006502997A (ja) 2006-01-26
ATE382355T1 (de) 2008-01-15
CN1671394A (zh) 2005-09-21
EP1524983A1 (de) 2005-04-27
DE50308933D1 (de) 2008-02-14
CA2493207A1 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
HRP20050173A2 (en) Composition containing an androgenous 11?-halogensteroid and a progestational hormone, and male contraceptive based on said comosition
HK1084941A1 (en) Compounds and their use
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
EP1632237A3 (en) Compositions comprising drospirenone and a complex between ethinyl-estradiol and a cyclodextrin
HK1078588A1 (en) Process to prepare eplerenone
MY129450A (en) Pharmaceutical composition
EP1105407A4 (en) AMINOSTEROLIC COMPOUNDS AND USES THEREOF
AU2002317298A1 (en) Formulation comprising fulvestrant
HK1060558A1 (en) 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof.
GB0202635D0 (en) Formulation containing novel anti-inflammatory androstane derivative
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
AU2003267551A1 (en) Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
RS20050049A (en) Composition containing an andogenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
AU2003285485A1 (en) 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
IL109866A0 (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (+) l-hydrogentartrate, its preparation and pharmaceutical compositions containing it
PT1635843E (pt) Terapia de substituição hormonal e de depressão compreendendo dienogest
WO2003035043A3 (en) Pharmaceutical formulation comprising more than 15% tamoxifen
WO1996028154A3 (de) Verwendung von antiestrogenen zur männlichen fertilitätskontrolle
AU2002240936A1 (en) Use of erss-selective ligands for regulating fertility and compounds useful therefore

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20090722

Year of fee payment: 7

OBST Application withdrawn